Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

BBOTBBOT
3 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in BRIDGEBIO ONCOLOGY THERAPEUT

BNP PARIBAS FINANCIAL MARKETS holds 191,152 shares of BBOT (BRIDGEBIO ONCOLOGY THERAPEUT), worth $1.5M as of 2026-Q2. The position was increased (+110.5% shares). BBOT represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.

Current Value

$1.5M

Current Shares

191,152

Total Value Change

+$1.1M

Total Shares Change

+164,680

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
191,152
+110.5%
$1.5M0.0%$7.62
41
2026-Q1
Increased
90,819
+243.1%
$812,8300.0%$9.74
40
2025-Q4
New
26,472
-
$331,4290.0%$12.37
33

Other major holders of BBOT: WELLINGTON MANAGEMENT GROUP LLP, Alphabet Inc., CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used